Editorial: Uncovering Drug Resistance During Cancer Therapy

Front Genet. 2022 Jul 19:13:945842. doi: 10.3389/fgene.2022.945842. eCollection 2022.

Haitao Wang¹, Rui-Hong Wang¹, Jian-Guo Zhou^{2

3

4

5}, Weilong Hou¹, Ada Hang-Heng Wong⁶

¹ Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NIH), Bethesda, MA, United States.
² Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
³ Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany.
⁴ Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany.
⁵ Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg (EMN), Erlangen, Germany.
⁶ AW Medical Co Ltd, Macao, Macao SAR, China.

No abstract available

Keywords: biomarkers; cancer; cancer therapy; drug resistance; next generation sequencing; oncology.

Publication types